HARRY G. Schiavi, chief executive officer
Harry G. Schiavi is a 30-year veteran of the pharma/biotech/med device market access space. He is the former Managing Partner and Executive Vice President of Precision Advisors, a leading Global Pricing, Market Access and Analytics consulting practice that services the pharma/biotech and medical device industries. Precision Advisors has advised 30 of the top 30 pharma/biotech companies in the world. Harry’s expertise has been called upon and noted in the Senate Permanent Sub Committee on Investigations Reports on Drug Pricing.
Prior to his role at Precision Advisors, Harry co-founded Insight Strategy Advisors (ISA), a Pricing & Market Access Consulting & Analytics company, in 2002. His company was acquired by Precision For Value & Health in December 2017. Harry began his career at Merck in sales and continued at AstraMerck in hospital/institution sales, regional/national account management, and headquarter roles in Market Access Marketing/Contracting. He later moved on to strategy consulting and held interim management roles for early-stage pharmaceutical and medical device companies.
Harry graduated from Davidson College with a degree in Economics.